Pantium (Pantoprazole)

Pantoprazole is used to treat conditions within the acid‑related disorder family by decreasing gastric acid secretion.

• Gastroesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of the esophageal lining.
• Erosive esophagitis: heals erosive lesions in the esophagus and alleviates associated pain.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion caused by gastrin‑producing tumors.
• Prevention of NSAID‑induced gastric ulcers: lowers the risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs.
• Helicobacter pylori eradication (as part of combination therapy): enhances eradication success when combined with appropriate antibiotics.

• Pantoprazole irreversibly binds to the cystic fibrosis transmembrane conductance regulator (CFTR‑linked) H⁺/K⁺‑ATPase (proton pump) located on the secretory surface of gastric parietal cells. By inhibiting this final step of acid production, it markedly lowers both basal and stimulated gastric acidity, allowing ulcerated tissue to heal and reducing the frequency of acid‑related symptoms. The inhibition is sustained for up to 72 hours, providing prolonged acid suppression after a single dose.

Pantoprazole may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Headache: mild to moderate pain often transient.
• Diarrhea: loose stools that may resolve with continued therapy.
• Nausea: feeling of queasiness without vomiting.
• Abdominal pain: discomfort in the stomach region.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing requiring immediate medical attention.
• Clostridioides difficile‑associated colitis: severe diarrhea with abdominal cramping, may occur during or after treatment.
• Low magnesium levels (hypomagnesemia): muscle weakness, irregular heartbeat, seizures if untreated.

Before prescribing Pantium, clinicians should consider several precautionary measures to ensure safe use.

• Assess renal function: adjust therapy in patients with severe renal impairment.
• Monitor magnesium levels: especially during prolonged treatment to avoid hypomagnesemia.
• Review hepatic status: use with caution in patients with moderate to severe liver disease.
• Evaluate concomitant medications: avoid known contraindicated drugs such as atazanavir, clopidogrel, and methotrexate.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Pantoprazole can affect the pharmacokinetics of several medicines, requiring attention to avoid clinically significant interactions.

Major Interactions (Avoid)

• Atazanavir: reduced antiviral absorption; avoid co‑administration.
• Clopidogrel: decreased antiplatelet effect; avoid concurrent use.
• Methotrexate: increased toxicity risk; avoid combination.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR; monitor coagulation parameters.
• Digoxin: may raise serum concentrations; check levels regularly.
• Ciclosporin: increased exposure; adjust dose and monitor renal function.